The noninferiority trial included 234 adults (five lost to follow-up) who were referred to seven sites across the U.S. for ...

Moderator Sagar Nigwekar, MD, of Massachusetts General Hospital in Boston, is joined by Edgar Lerma, MD, of the University of ...

As-needed use of a metered-dose inhaler with albuterol plus budesonide (Airsupra) lowered the risk of severe exacerbations ...

Novel oral agent nerandomilast slowed lung capacity decline in patients with non-idiopathic pulmonary fibrosis (IPF) ...

Robert F. Kennedy Jr. clinched the political support needed to become the nation's top health official by pledging to work ...

During a call with U.S. doctors this month, one CDC official noted that there is a seasonality to bird flu: Cases peak in the ...

People who died by suicide frequently presented to hospitals within the previous year, indicating that these visits could be ...

LOS ANGELES -- Asian American and Pacific Islander sexual and gender minority young adults are at increased risk of substance ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

Childhood cancer survivors had a twofold higher adjusted risk of CKD or hypertension versus the hospitalized cohort (adjusted HR 2.00, 95% CI 1.86-2.14, P <0.001) and a fourfold higher adjusted risk ...

ORLANDO -- Palopegteriparatide (Yorvipath) led to sustained improvements over 2 years in adults with chronic ...

For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks ...